August 9, 2026

Newsletter

The European Post

Policy • Diplomacy • Strategic Insight

LATEST
New EU Gas Market Rules Take Effect With Consumer SafeguardsDeforestation Regulation Holds Its December Deadline Despite CutsDigital Omnibus Delays Europe’s High-Risk AI Deadline to 2027Europe’s Schools Confront a Widening Basic Skills GapRule of Law Report Finds Progress but Trust Still LagsIRIS2 Gains 66 Satellites as Brussels Signs the Rollout DealNature Restoration Plans Come Due as Member States Race a DeadlineECB Rates Hold at 2.25 Percent as Frankfurt Waits on the DataEU Budget Talks Turn to Cohesion as Ireland Takes OverWildfire Response Stretches Europe’s Emergency Fleet ThinCan Europe’s Quantum Plan Match Its Big Ambitions?Armenia Edges West as Moscow’s Grip Slips AwayEurope Inherits the World’s Aid Bill It Cannot Fully PayAir Passenger Rights Get Their First Overhaul in Two DecadesErasmus Opens a 5 Billion Euro Round for Skills and MobilityCeuta Crisis Pushes the EU Toward Faster Migrant ReturnsBulky Parcels Face a Packaging Crackdown From August 12Can Europe Build Its Drone Wall Before 2030 Arrives?Indonesia’s Trade Deal With Europe Nears Its Final SignatureEurope Leans on Beijing to Keep Climate Talks Alive Before AntalyaNew EU Gas Market Rules Take Effect With Consumer SafeguardsDeforestation Regulation Holds Its December Deadline Despite CutsDigital Omnibus Delays Europe’s High-Risk AI Deadline to 2027Europe’s Schools Confront a Widening Basic Skills GapRule of Law Report Finds Progress but Trust Still LagsIRIS2 Gains 66 Satellites as Brussels Signs the Rollout DealNature Restoration Plans Come Due as Member States Race a DeadlineECB Rates Hold at 2.25 Percent as Frankfurt Waits on the DataEU Budget Talks Turn to Cohesion as Ireland Takes OverWildfire Response Stretches Europe’s Emergency Fleet ThinCan Europe’s Quantum Plan Match Its Big Ambitions?Armenia Edges West as Moscow’s Grip Slips AwayEurope Inherits the World’s Aid Bill It Cannot Fully PayAir Passenger Rights Get Their First Overhaul in Two DecadesErasmus Opens a 5 Billion Euro Round for Skills and MobilityCeuta Crisis Pushes the EU Toward Faster Migrant ReturnsBulky Parcels Face a Packaging Crackdown From August 12Can Europe Build Its Drone Wall Before 2030 Arrives?Indonesia’s Trade Deal With Europe Nears Its Final SignatureEurope Leans on Beijing to Keep Climate Talks Alive Before Antalya
August 9, 2026

Newsletter

The European Post

Policy • Diplomacy • Strategic Insight

LATEST
New EU Gas Market Rules Take Effect With Consumer SafeguardsDeforestation Regulation Holds Its December Deadline Despite CutsDigital Omnibus Delays Europe’s High-Risk AI Deadline to 2027Europe’s Schools Confront a Widening Basic Skills GapRule of Law Report Finds Progress but Trust Still LagsIRIS2 Gains 66 Satellites as Brussels Signs the Rollout DealNature Restoration Plans Come Due as Member States Race a DeadlineECB Rates Hold at 2.25 Percent as Frankfurt Waits on the DataEU Budget Talks Turn to Cohesion as Ireland Takes OverWildfire Response Stretches Europe’s Emergency Fleet ThinCan Europe’s Quantum Plan Match Its Big Ambitions?Armenia Edges West as Moscow’s Grip Slips AwayEurope Inherits the World’s Aid Bill It Cannot Fully PayAir Passenger Rights Get Their First Overhaul in Two DecadesErasmus Opens a 5 Billion Euro Round for Skills and MobilityCeuta Crisis Pushes the EU Toward Faster Migrant ReturnsBulky Parcels Face a Packaging Crackdown From August 12Can Europe Build Its Drone Wall Before 2030 Arrives?Indonesia’s Trade Deal With Europe Nears Its Final SignatureEurope Leans on Beijing to Keep Climate Talks Alive Before AntalyaNew EU Gas Market Rules Take Effect With Consumer SafeguardsDeforestation Regulation Holds Its December Deadline Despite CutsDigital Omnibus Delays Europe’s High-Risk AI Deadline to 2027Europe’s Schools Confront a Widening Basic Skills GapRule of Law Report Finds Progress but Trust Still LagsIRIS2 Gains 66 Satellites as Brussels Signs the Rollout DealNature Restoration Plans Come Due as Member States Race a DeadlineECB Rates Hold at 2.25 Percent as Frankfurt Waits on the DataEU Budget Talks Turn to Cohesion as Ireland Takes OverWildfire Response Stretches Europe’s Emergency Fleet ThinCan Europe’s Quantum Plan Match Its Big Ambitions?Armenia Edges West as Moscow’s Grip Slips AwayEurope Inherits the World’s Aid Bill It Cannot Fully PayAir Passenger Rights Get Their First Overhaul in Two DecadesErasmus Opens a 5 Billion Euro Round for Skills and MobilityCeuta Crisis Pushes the EU Toward Faster Migrant ReturnsBulky Parcels Face a Packaging Crackdown From August 12Can Europe Build Its Drone Wall Before 2030 Arrives?Indonesia’s Trade Deal With Europe Nears Its Final SignatureEurope Leans on Beijing to Keep Climate Talks Alive Before Antalya

Europe Bets on Home-Made Antibiotics to End Its Drug Shortages

Rudolf Nureyev
Parliament Reporter, Health and Wellbeing

Strasbourg: When a child cannot get antibiotics or a diabetic struggles to find insulin, the failure feels intimate, but its causes are industrial and global. The European Union’s answer took clearer shape on 12 May, when negotiators from the Council and the European Parliament struck a provisional deal on the Critical Medicines Act, a regulation designed to pull the manufacture of essential drugs and their ingredients back toward European soil. The European Medicines Agency welcomed the agreement; the harder work of proving it changes anything has only begun.

The diagnosis behind the law is uncontested. Europe has spent years lurching from one shortage to the next, antibiotics, painkillers, cancer therapies, and much of the vulnerability traces to a supply chain that concentrates production of active pharmaceutical ingredients in a handful of plants, many in Asia. A single factory closure or export restriction can ripple across the continent within weeks. The Act tries to build resilience into the system rather than reacting after the shelves empty.

Its mechanisms are pragmatic. Public procurement for critical medicines will have to weigh resilience and security of supply, not price alone, a quiet but consequential break with the logic that pushed manufacturing offshore in the first place. The threshold for member states to ask the Commission to run joint procurement on their behalf drops from nine countries to five, making collective purchasing easier to trigger. And the regulation creates room for incentives and contingency stockpiling, with safeguards meant to keep stock requirements transparent and proportional so that one country’s hoarding does not become another’s shortage.

The objections are equally serious. Manufacturing capacity does not appear because a regulation wishes it into being; it requires sustained investment, and buy-European procurement can raise costs for already stretched health budgets. Critics warn that resilience requirements, if written clumsily, could narrow the field of suppliers and paradoxically make some shortages worse. There is also the question of money. The Act leans heavily on national and private investment rather than a large dedicated EU fund, leaving open whether the ambition is matched by financing. Industry groups have welcomed the direction while pressing for predictable rules and faster permitting for new plants.

Then there is timing. The agreed text still needs formal sign-off from both the Council and Parliament, and publication in the Official Journal is not expected until late 2026, with the application date to be confirmed. In practice the first reshoring decisions are years away, and a winter shortage season will arrive long before the law bites.

What the Critical Medicines Act represents, more than any single provision, is a shift in how Brussels thinks about health. For decades medicine supply was treated as a market to be optimised for efficiency. The pandemic, and the shortages that followed, reframed it as a question of strategic autonomy, closer to energy or defence than to ordinary trade. The Act will not stock a single pharmacy this year. But it marks the moment the EU decided that knowing where its antibiotics come from is worth paying for, a judgment whose price tag, and payoff, the next few years will reveal.

Comments